Hereditary transthyretin (hATTR) amyloidosis is a rare progressive disease that is passed from parent to child. It is caused ...

As the name suggests, hereditary transthyretin amyloidosis (hATTR) with polyneuropathy runs in families. If you have it, you got it from genes one or both of your parents passed to you.

Wainua (eplontersen) is a prescription injection medicine that slows down nerve damage in people with a type of amyloidosis called hereditary transthyretin-mediated amyloidosis (hATTR). The FDA ...

Before her diagnosis with hereditary ATTR (hATTR) amyloidosis, Gail had a healthy, active social life. She was a professional concert pianist and university professor of piano. She founded an inter… ...

Alnylam is using Twitter and a new website to run a European-based awareness campaign for a rare condition known as hereditary ATTR (hATTR) amyloidosis. This genetic condition is a physically ...

WASHINGTON – Angel says her family has been living with a rare disease they called “the curse” for generations. Known as hATTR Amyloidosis, the life-threatening condition was first ...

The road trip trope is alive and well in medical marketing, as Alnylam Pharmaceuticals recently utilized the motif to raise awareness of hereditary ATTR (hATTR) amyloidosis. Last week, the ...

NICE has recommended that Akcea’s hereditary transthyretin-related amyloidosis (hATTR) treatment Tegsedi be made available on the NHS in England, ahead of a rival therapy from Alnylam.

CAMBRIDGE, Mass., March 13, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the launch of the Family Health History Road Trip, its program ...

There are two different forms of ATTR amyloidosis — hereditary ATTR (hATTR) amyloidosis, which is caused by a TTR gene variant and affects approximately 50,000 people worldwide, and wild-type ...

New study published in the BMJ Open calls for major shift in the management of hATTR amyloidosis Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced ...